GlaxoSmithKline Australia Pty Ltd

424 result(s) found, displaying 1 to 10

BLENREP belantamab mafodotin 70 mg powder for injection vial (464326)

18 November 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BLENREP belantamab mafodotin 70 mg powder for injection vial.
BLENREP belantamab mafodotin 100 mg powder for injection vial (464325)

17 November 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BLENREP belantamab mafodotin 100 mg powder for injection vial.
AREXVY GlaxoSmithKline Australia Pty Ltd

Oct-2025

Prescription medicine evaluation

Active ingredient: recombinant respiratory syncytial virus pre-fusion F protein.
FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule Cancelled under Section 30(1)(c) of the Act

21 October 2025

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
FLIXOTIDE NEBULES fluticasone propionate 0.5mg/2mL inhalation ampoule Cancelled under Section 30(1)(c) of the Act

21 October 2025

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
FLIXONASE NASULE DROPS fluticasone propionate 400mcg unit dose ampoule strip pack Cancelled under Section 30(1)(c) of the Act

21 October 2025

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL injection vial plus diluent ampoule composite pack Cancelled under Section 30(1)(a) of the Act

24 July 2025

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL powder for injection vial Cancelled under Section 30(1)(a) of the Act

24 July 2025

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
GlaxoSmithKline Australia Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use Cancelled under Section 41GL(d) of the Act

15 July 2025

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
GlaxoSmithKline Australia Pty Ltd - Inhaler, aerosol, portable Cancelled under Section 41GL(d) of the Act

11 July 2025

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

GlaxoSmithKline Australia Pty Ltd

BLENREP belantamab mafodotin 70 mg powder for injection vial (464326)

BLENREP belantamab mafodotin 100 mg powder for injection vial (464325)

AREXVY GlaxoSmithKline Australia Pty Ltd

FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule Cancelled under Section 30(1)(c) of the Act

FLIXOTIDE NEBULES fluticasone propionate 0.5mg/2mL inhalation ampoule Cancelled under Section 30(1)(c) of the Act

FLIXONASE NASULE DROPS fluticasone propionate 400mcg unit dose ampoule strip pack Cancelled under Section 30(1)(c) of the Act

VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL injection vial plus diluent ampoule composite pack Cancelled under Section 30(1)(a) of the Act

VARILRIX HSA-FREE varicella vaccine live attenuated 0.5mL powder for injection vial Cancelled under Section 30(1)(a) of the Act

GlaxoSmithKline Australia Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use Cancelled under Section 41GL(d) of the Act

GlaxoSmithKline Australia Pty Ltd - Inhaler, aerosol, portable Cancelled under Section 41GL(d) of the Act

Is there anything wrong with this page?

GlaxoSmithKline Australia Pty Ltd

Type

Date

Is there anything wrong with this page?